Archives
Ampicillin Sodium: Mechanism, Evidence & Antibacterial As...
Ampicillin Sodium: Mechanism, Evidence & Antibacterial Assay Guide
Executive Summary: Ampicillin sodium (CAS 69-52-3) is a β-lactam antibiotic with high purity (98%) and proven efficacy in both Gram-positive and Gram-negative bacteria (Cullmann et al. 1982). Its primary mechanism is the competitive inhibition of bacterial transpeptidase enzymes, which disrupts cell wall biosynthesis and leads to cell lysis (APExBIO). The compound demonstrates an IC50 of 1.8 μg/mL against E. coli 146 transpeptidase, and a minimum inhibitory concentration (MIC) of 3.1 μg/mL under standard in vitro conditions. Ampicillin sodium is water-soluble (≥18.57 mg/mL) and is widely used in both in vitro and animal infection model research (related article). Solutions should be used promptly due to limited long-term stability.
Biological Rationale
Ampicillin sodium is a core member of the β-lactam antibiotic class, used to target bacterial infections through the inhibition of peptidoglycan cross-linking. By targeting transpeptidase enzymes, it interferes with bacterial cell wall biosynthesis, a process essential for maintaining cell integrity, especially in rapidly dividing bacteria (Cullmann et al. 1982). The compound is effective against both Gram-positive and Gram-negative pathogens, supporting its widespread use in antibacterial activity assays and translational research (Gentamycin-Sulfate.com). APExBIO supplies Ampicillin sodium (SKU: A2510) with verified lot-to-lot purity and documentation, facilitating reproducibility in experimental workflows (APExBIO).
Mechanism of Action of Ampicillin sodium
Ampicillin sodium functions as a competitive inhibitor of bacterial transpeptidase enzymes. These enzymes catalyze the cross-linking of peptidoglycan strands during the final steps of bacterial cell wall biosynthesis. By binding to the active site of transpeptidase, Ampicillin sodium prevents the formation of cross-links, resulting in a weakened cell wall and subsequent bacterial cell lysis (DOI). This mechanism is conserved across both Gram-positive and Gram-negative bacteria, although variations in outer membrane permeability and β-lactamase activity influence susceptibility.
- Target: Transpeptidase enzymes (penicillin-binding proteins, PBPs).
- Inhibition Type: Competitive.
- Effect: Loss of cell wall integrity, osmotic lysis of bacteria.
- Quantitative Activity: IC50 = 1.8 μg/mL (E. coli 146), MIC = 3.1 μg/mL (standard broth; 37°C, pH 7.2) (Cullmann et al. 1982).
For an in-depth molecular perspective and advanced assay strategies, see "Ampicillin Sodium: Molecular Insights & Innovations in β-Lactam Research", which this guide updates with additional evidence on transpeptidase inhibition kinetics.
Evidence & Benchmarks
- Ampicillin sodium inhibits E. coli transpeptidase with an IC50 of 1.8 μg/mL (Cullmann et al. 1982, DOI).
- The minimum inhibitory concentration (MIC) for E. coli 146 is 3.1 μg/mL under standard conditions (Cullmann et al. 1982, DOI).
- Active against both Gram-positive and Gram-negative bacteria, including ampicillin-resistant Enterobacteriaceae (MIC >16 μg/mL in resistant strains) (DOI).
- Comparable activity to thienamycin derivatives against Streptococcus faecalis and selected Gram-negative strains (DOI).
- Solubility: ≥18.57 mg/mL in water, ≥73.6 mg/mL in DMSO, ≥75.2 mg/mL in ethanol (APExBIO QC data, APExBIO).
- Supplied at 98% purity with COA, NMR, and MS validation (APExBIO, APExBIO).
This article extends the workflow-focused guidance in "Ampicillin Sodium: Optimizing Antibacterial Activity Assays" by benchmarking experimental results against peer-reviewed MIC and IC50 data.
Applications, Limits & Misconceptions
Ampicillin sodium is a standard for:
- Antibacterial activity assays (broth dilution, disc diffusion).
- Bacterial infection models in animals (murine, avian, etc.).
- Selective pressure in recombinant protein workflows (plasmid selection).
- Antibiotic resistance research, especially for β-lactamase studies (YTBroth.com).
Common Pitfalls or Misconceptions
- Not effective against bacteria expressing high levels of β-lactamase enzymes (resistance can occur via hydrolysis of the β-lactam ring).
- Reduced permeability through the outer membrane of some Gram-negative bacteria can limit efficacy.
- Not suitable for long-term solution storage; degradation occurs above -20°C or after repeated freeze-thaw cycles.
- Does not inhibit non-bacterial pathogens (e.g., viruses, fungi).
- MIC values are assay- and strain-dependent; direct comparison across studies requires matched conditions.
Workflow Integration & Parameters
For reliable results in antibacterial activity assays:
- Use freshly prepared solutions; avoid long-term storage of working stocks.
- Recommended storage: -20°C, shipped with blue ice (APExBIO guidelines, product page).
- Common working concentrations: 25–100 μg/mL for selective media; adjust for MIC or IC50 determinations.
- Monitor for β-lactamase production when interpreting negative assay results.
For advanced mechanistic and translational insights, the article "Ampicillin Sodium in Translational Research" provides frameworks for integrating this compound into innovative bacterial model systems. This current guide emphasizes reproducible benchmarking and the impact of purity and solubility on assay fidelity.
Conclusion & Outlook
Ampicillin sodium is a validated β-lactam antibiotic with well-characterized mechanisms and benchmarks for antibacterial activity. Its effectiveness as a competitive transpeptidase inhibitor is supported by peer-reviewed data and quality-controlled supply from APExBIO. It remains a standard for antibacterial assay calibration, resistance mechanism studies, and translational research involving both Gram-positive and Gram-negative bacteria. Researchers are advised to match experimental conditions to published benchmarks and to account for resistance determinants such as β-lactamase expression for optimal results.